title: Inhibition of the IGF-I receptor for treatment of cancer. Kinase inhibitors and monoclonal antibodies as alternative approaches.
authors.affiliation: Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.
authors.forename: Yan
authors.initials: Y
authors.lastname: Wang
authors.forename: Qun-Sheng
authors.initials: QS
authors.lastname: Ji
authors.forename: Mark
authors.initials: M
authors.lastname: Mulvihill
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Pachter
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology*; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D017526:Receptor, IGF Type 1 / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D047428:Protein Kinase Inhibitors; D017526:Receptor, IGF Type 1